Literature DB >> 34185705

Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression.

Kazuhiro Shiizaki1,2, Asako Tsubouchi3, Yutaka Miura1, Kinya Seo4, Takahiro Kuchimaru5, Hirosaka Hayashi1, Yoshitaka Iwazu1,6,7, Marina Miura1,6, Batpurev Battulga8, Nobuhiko Ohno8,9, Toru Hara10, Rina Kunishige3, Mamiko Masutani11, Keita Negishi12, Kazuomi Kario12, Kazuhiko Kotani7, Toshiyuki Yamada7, Daisuke Nagata6, Issei Komuro13, Hiroshi Itoh14, Hiroshi Kurosu1, Masayuki Murata3, Makoto Kuro-O1.   

Abstract

The Western pattern diet is rich not only in fat and calories but also in phosphate. The negative effects of excessive fat and calorie intake on health are widely known, but the potential harms of excessive phosphate intake are poorly recognized. Here, we show the mechanism by which dietary phosphate damages the kidney. When phosphate intake was excessive relative to the number of functioning nephrons, circulating levels of FGF23, a hormone that increases the excretion of phosphate per nephron, were increased to maintain phosphate homeostasis. FGF23 suppressed phosphate reabsorption in renal tubules and thus raised the phosphate concentration in the tubule fluid. Once it exceeded a threshold, microscopic particles containing calcium phosphate crystals appeared in the tubule lumen, which damaged tubule cells through binding to the TLR4 expressed on them. Persistent tubule damage induced interstitial fibrosis, reduced the number of nephrons, and further boosted FGF23 to trigger a deterioration spiral leading to progressive nephron loss. In humans, the progression of chronic kidney disease (CKD) ensued when serum FGF23 levels exceeded 53 pg/mL. The present study identified calcium phosphate particles in the renal tubular fluid as an effective therapeutic target to decelerate nephron loss during the course of aging and CKD progression.

Entities:  

Keywords:  Chronic kidney disease; Nephrology

Mesh:

Substances:

Year:  2021        PMID: 34185705      PMCID: PMC8363285          DOI: 10.1172/JCI145693

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

Review 1.  Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon.

Authors:  Wajeh Y Qunibi; Charles A Nolan; J Carlos Ayus
Journal:  Kidney Int Suppl       Date:  2002-12       Impact factor: 10.545

2.  Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.

Authors:  Michal L Melamed; Edward J Horwitz; Mirela A Dobre; Matthew K Abramowitz; Liping Zhang; Yungtai Lo; William E Mitch; Thomas H Hostetter
Journal:  Am J Kidney Dis       Date:  2019-11-05       Impact factor: 8.860

Review 3.  Chronic Kidney Disease.

Authors:  Angela C Webster; Evi V Nagler; Rachael L Morton; Philip Masson
Journal:  Lancet       Date:  2016-11-23       Impact factor: 79.321

4.  Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial.

Authors:  Kenji Ueshima; Hiroshi Itoh; Nobuaki Kanazawa; Issei Komuro; Ryozo Nagai; Masahiro Takeuchi; Tsutomu Yamazaki
Journal:  J Atheroscler Thromb       Date:  2016-03-08       Impact factor: 4.928

5.  Acute phosphate nephropathy-an emerging threat.

Authors:  Yaacov Ori; Michal Herman; Ana Tobar; Gil Chernin; Uzi Gafter; Avry Chagnac; Ofer Ben Izhak; Asher Korzets
Journal:  Am J Med Sci       Date:  2008-10       Impact factor: 2.378

6.  Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance.

Authors:  Durba Pal; Suman Dasgupta; Rakesh Kundu; Sudipta Maitra; Gobardhan Das; Satinath Mukhopadhyay; Sukanta Ray; Subeer S Majumdar; Samir Bhattacharya
Journal:  Nat Med       Date:  2012-07-29       Impact factor: 53.440

Review 7.  Is bowel preparation before colonoscopy a risky business for the kidney?

Authors:  Yeong-Hau H Lien
Journal:  Nat Clin Pract Nephrol       Date:  2008-09-16

8.  Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.

Authors:  Takashi Shimada; Makoto Kakitani; Yuji Yamazaki; Hisashi Hasegawa; Yasuhiro Takeuchi; Toshiro Fujita; Seiji Fukumoto; Kazuma Tomizuka; Takeyoshi Yamashita
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

Review 9.  The Klotho proteins in health and disease.

Authors:  Makoto Kuro-O
Journal:  Nat Rev Nephrol       Date:  2019-01       Impact factor: 28.314

Review 10.  Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.

Authors:  Nathan R Hill; Samuel T Fatoba; Jason L Oke; Jennifer A Hirst; Christopher A O'Callaghan; Daniel S Lasserson; F D Richard Hobbs
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

View more
  12 in total

1.  Calcium phosphate crystals: targets for renoprotection.

Authors:  Monica Wang
Journal:  Nat Rev Nephrol       Date:  2021-07-26       Impact factor: 28.314

2.  A generic crystallopathic model for chronic kidney disease progression.

Authors:  Orson W Moe
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 19.456

3.  Exercising the FGF23-Cardiac Axis.

Authors:  Susan L Murray; Myles Wolf
Journal:  Kidney360       Date:  2022-09-29

Review 4.  Lipocalin-2: a novel link between the injured kidney and the bone.

Authors:  Guillaume Courbon; Valentin David
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-07-01       Impact factor: 3.416

Review 5.  Contribution of phosphate and FGF23 to CKD progression.

Authors:  Kyle P Jansson; Alan S L Yu; Jason R Stubbs
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-03-11       Impact factor: 3.416

Review 6.  Emerging cross-talks between chronic kidney disease-mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis.

Authors:  Shunsuke Yamada; Kazuhiko Tsuruya; Takanari Kitazono; Toshiaki Nakano
Journal:  Clin Exp Nephrol       Date:  2022-03-30       Impact factor: 2.617

7.  Renoprotective effects of ferric citrate in a mouse model of chronic kidney disease.

Authors:  Mark R Hanudel; Brian Czaya; Shirley Wong; Grace Jung; Kristine Chua; Bo Qiao; Victoria Gabayan; Tomas Ganz
Journal:  Sci Rep       Date:  2022-04-23       Impact factor: 4.996

8.  Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling.

Authors:  Brian Czaya; Kylie Heitman; Isaac Campos; Christopher Yanucil; Dominik Kentrup; David Westbrook; Orlando Gutierrez; Jodie L Babitt; Grace Jung; Isidro B Salusky; Mark Hanudel; Christian Faul
Journal:  Elife       Date:  2022-03-18       Impact factor: 8.713

Review 9.  The emerging role of magnesium in CKD.

Authors:  Yusuke Sakaguchi
Journal:  Clin Exp Nephrol       Date:  2022-01-25       Impact factor: 2.617

Review 10.  Klotho and calciprotein particles as therapeutic targets against accelerated ageing.

Authors:  Makoto Kuro-O
Journal:  Clin Sci (Lond)       Date:  2021-08-13       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.